AAV for ovarian cancer gene therapy

Hee Chan Yoo1,2, Sangkil Lee3,4, Joong Yull Park4,5

  • 1College of Pharmacy, Chung-Ang University, Seoul, Republic of Korea. heechan@cau.ac.kr.

Cancer Gene Therapy
|June 20, 2025
PubMed

Insights

Adeno-associated virus (AAV) vectors show promise for ovarian cancer gene therapy, targeting cancer stem cells and utilizing gene supplementation for improved treatment outcomes. This approach aims to overcome treatment resistance and enhance long-term survival for ovarian cancer patients.

Area of Science:

  • Oncology
  • Gene Therapy
  • Virology

Background:

  • PARP inhibitors improved ovarian cancer recurrence-free intervals, but relapse remains a challenge.
  • Ovarian cancer survival rates lag behind other female cancers, necessitating novel therapeutic strategies.
  • Gene therapy using adeno-associated virus (AAV) vectors presents a potential new avenue for ovarian cancer treatment.

Purpose of the Study:

  • To review the potential of AAV vectors for gene therapy in ovarian cancer.
  • To examine rational gene therapy strategies by categorizing them based on target cells and genes.
  • To identify effective AAV-based gene therapy approaches for ovarian cancer.

Main Methods:

  • Review of current literature on AAV vectors and ovarian cancer.
  • Categorization of gene therapy strategies including anti-angiogenesis, immune modulation, and gene supplementation.
  • Exploration of targeted delivery methods focusing on ovarian cancer stem cells (CSCs).

Main Results:

  • AAV vectors offer potential for targeted gene delivery in ovarian cancer.
  • Gene supplementation strategies show promise in hindering ovarian cancer progression.
  • Innovations in AAV capsid design enable targeting of specific ovarian cancer stem cell markers.

Conclusions:

  • AAV-mediated gene therapy is a promising strategy for ovarian cancer treatment.
  • Targeted delivery to CSCs and gene supplementation are key therapeutic approaches.
  • Advancements in AAV technology and DNA sequencing enhance the potential for effective ovarian cancer gene therapy.

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.8K
Gene Therapy00:59

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
25.9K
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
8.0K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K